Argenx Posts Higher H1 Attributable Profit, Product Net Sales

01:30 AM EDT, 07/23/2026 (MT Newswires) -- Argenx (ARGX.BR) said Thursday that attributable profit and product net sales for the first half rose year over year. Profit attributable to owners of the parent for the six months ended June 30 was $838 million, compared with $415 million a year earlier. EPS moved to $13 from $6.32. The immunology company's product net sales were $2.81 billion, compared with $1.74 billion a year ago.